Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SmithKline Beecham describes 5-HT1D antagonists

June 14, 1996

Compounds with melatonin receptor affinity from Takeda

June 14, 1996

5-HT2B/2C antagonists reported by SmithKline Beecham

June 14, 1996

Further ADIR research on melatonergic compounds

June 14, 1996

Zeneca reveals prostaglandin antagonists

June 14, 1996

ADIR claims tachykinin antagonists

June 14, 1996

Dopamine D4 receptor ligands discovered by Pfizer

June 7, 1996

Clinical trials anticipated for CoCensys' and Ciba-Geigy's codeveloped EAA antagonist

June 7, 1996

Ciba-Geigy discloses glycine-site NMDA antagonists

June 7, 1996

BASF reports glutamate receptor antagonists

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...